[HTML][HTML] Diagnostic and prognostic plasma biomarkers for idiopathic pneumonia syndrome after hematopoietic cell transplantation
S Seo, J Yu, IC Jenkins, WM Leisenring… - Biology of Blood and …, 2018 - Elsevier
Idiopathic pneumonia syndrome (IPS) is a noninfectious pulmonary complication after
hematopoietic cell transplantation (HCT) and is difficult to diagnose. In 41 patients with IPS …
hematopoietic cell transplantation (HCT) and is difficult to diagnose. In 41 patients with IPS …
[HTML][HTML] Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation
DS Wenger, M Triplette, K Crothers, GS Cheng… - Biology of Blood and …, 2020 - Elsevier
Our current knowledge of idiopathic pneumonia syndrome (IPS) predates improved
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …
Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies
Newer diagnostic methods may link more idiopathic pneumonia syndrome (IPS) cases to an
infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell …
infectious agent. Bronchoalveolar lavage (BAL) samples from 69 hematopoietic cell …
Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation
KE Zhu, JY Hu, T Zhang, J Chen… - European journal of …, 2008 - Wiley Online Library
We retrospectively analyzed 23 cases with early‐onset idiopathic pneumonia syndrome
(IPS) of 192 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) …
(IPS) of 192 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) …
An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome
A Panoskaltsis-Mortari, M Griese… - American journal of …, 2011 - atsjournals.org
Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic pneumonia
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …
[HTML][HTML] Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome
Idiopathic pneumonia syndrome (IPS) is a complication of allogeneic hematopoietic stem
cell transplantation (HSCT) that typically occurs within the first 100 days after transplantation …
cell transplantation (HSCT) that typically occurs within the first 100 days after transplantation …
[HTML][HTML] Proteome profiling in lung injury after hematopoietic stem cell transplantation
M Bhargava, KJ Viken, S Dey, MS Steinbach… - Biology of Blood and …, 2016 - Elsevier
Pulmonary complications due to infection and idiopathic pneumonia syndrome (IPS), a
noninfectious lung injury in hematopoietic stem cell transplant (HSCT) recipients, are …
noninfectious lung injury in hematopoietic stem cell transplant (HSCT) recipients, are …
High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation: based on the updated concept of idiopathic pneumonia …
Idiopathic pneumonia syndrome (IPS) is an acute lung dysfunction of non-infectious
aetiology and a severe complication following haematopoietic stem cell transplantation …
aetiology and a severe complication following haematopoietic stem cell transplantation …
Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients
J Keates-Baleeiro, P Moore, T Koyama… - Bone marrow …, 2006 - nature.com
Idiopathic pneumonia syndrome (IPS) is a rare complication following stem cell transplant
(SCT) and its incidence among pediatric SCT recipients is not known. To assess the …
(SCT) and its incidence among pediatric SCT recipients is not known. To assess the …
[HTML][HTML] Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia …
GA Yanik, MM Horowitz, DJ Weisdorf, BR Logan… - Biology of Blood and …, 2014 - Elsevier
Idiopathic pneumonia syndrome (IPS) is a diffuse, noninfectious lung injury that occurs
acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has …
acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has …